tradingkey.logo

tradingkey.logo
怜玢


Catheter Precision Inc

VTAK
りォッチリストに远加
0.152USD
+0.004+2.70%
終倀 09-22 16:00ET
548.72K時䟡総額
損倱額盎近12ヶ月PER
前堎取匕 07:00 (ET)0.156USD+0.004+2.63%

Catheter Precision Incに぀いお 䌁業名

Catheter Precision, Inc. is a medical device company bringing solutions to market to improve the treatment of cardiac arrhythmias. The Company is focused on developing technology for electrophysiology (EP) procedures by collaborating with physicians and continuously advancing its products. The Company's two primary products are the View into Ventricular Onset System (VIVO System) and LockeT. The VIVO System is a non-invasive imaging system that offers three-dimensional (3D) cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. Its product, LockeT, is a suture retention device indicated for wound healing by distributing suture tension over a larger area in the patient in conjunction with a figure of eight suture closure. Its product portfolio also includes the Amigo Remote Catheter System. It is developing technology for the treatment of acute decompensated heart failure.

Catheter Precision Inc プロフィヌル


䌁業コヌドVTAK
䌚瀟名Catheter Precision Inc
䞊堎日Sep 27, 2018
最高経営責任者「CEO」Jenkins (David A)
埓業員数22
蚌刞皮類Ordinary Share
決算期末Sep 27
本瀟所圚地1670 Highway 160 West
郜垂FORT MILL
蚌刞取匕所NASDAQ OMX – NASDAQ Basic Amex
囜United States of America
郵䟿番号29708
電話番号19736912000
りェブサむトhttps://www.ramed.com/
䌁業コヌドVTAK
䞊堎日Sep 27, 2018
最高経営責任者「CEO」Jenkins (David A)

Catheter Precision Incの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. David Jenkins
Mr. David Jenkins
Executive Chairman of the Board, Chief Executive Officer, Chief Commercial Officer
Executive Chairman of the Board, Chief Executive Officer, Chief Commercial Officer
938.49K
+94.83%
Mr. David Jenkins
Mr. David Jenkins
Executive Chairman of the Board, Chief Executive Officer, Chief Commercial Officer
Executive Chairman of the Board, Chief Executive Officer, Chief Commercial Officer
938.49K
+94.83%
Mr. Martin J. Colombatto
Mr. Martin J. Colombatto
Independent Director
Independent Director
2.00
--
Mr. Martin J. Colombatto
Mr. Martin J. Colombatto
Independent Director
Independent Director
2.00
--
Mr. James J. Caruso
Mr. James J. Caruso
Independent Director
Independent Director
--
--
Mr. Tony Dacosta
Mr. Tony Dacosta
Investor Relations
Investor Relations
--
--
Mr. Philip J. (Phil) Anderson
Mr. Philip J. (Phil) Anderson
Chief Financial Officer, Secretary
Chief Financial Officer, Secretary
--
--
Mr. Andrew (Andy) Arno
Mr. Andrew (Andy) Arno
Independent Director
Independent Director
--
--
Mr. James J. Caruso
Mr. James J. Caruso
Independent Director
Independent Director
--
--
Mr. Tony Dacosta
Mr. Tony Dacosta
Investor Relations
Investor Relations
--
--
詳现を芋る
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. David Jenkins
Mr. David Jenkins
Executive Chairman of the Board, Chief Executive Officer, Chief Commercial Officer
Executive Chairman of the Board, Chief Executive Officer, Chief Commercial Officer
938.49K
+94.83%
Mr. David Jenkins
Mr. David Jenkins
Executive Chairman of the Board, Chief Executive Officer, Chief Commercial Officer
Executive Chairman of the Board, Chief Executive Officer, Chief Commercial Officer
938.49K
+94.83%
Mr. Martin J. Colombatto
Mr. Martin J. Colombatto
Independent Director
Independent Director
2.00
--
Mr. Martin J. Colombatto
Mr. Martin J. Colombatto
Independent Director
Independent Director
2.00
--
Mr. James J. Caruso
Mr. James J. Caruso
Independent Director
Independent Director
--
--
Mr. Tony Dacosta
Mr. Tony Dacosta
Investor Relations
Investor Relations
--
--

よくある質問

Catheter Precision Incの䞊䜍5名の株䞻は誰ですか


Catheter Precision Incの䞊䜍5名の株䞻は以䞋のずおりです。Mr. David Jenkins

Catheter Precision IncVTAKの株匏を保有しおいる機関の数はいく぀ですか


2026Q1時点で、Catheter Precision Incの株匏を保有しおいる機関は28瀟あり、保有株匏の総垂堎䟡倀は玄304.48Kで、党䜓の11.31%を占めおいたす。2025Q4ず比范しお、機関の持ち株は230261.00増加しおいたす。
tradingkey.logo
リスク告知圓瀟りェブサむト及びモバむルアプリは特定の投資商品に関する䞀般的な情報のみを提䟛しおおり、Finsightsは金融アドバむスや投資商品の掚奚を行うものではありたせん。本情報の提䟛をもっおFinsightsが投資助蚀を行っおいるず解釈されるこずはありたせん。
投資商品には元本割れを含む重倧なリスクが䌎い、党おの投資家に適するものではありたせん。なお、過去の運甚実瞟は将来の成果を保蚌するものではありたせん。
Finsightsは、第䞉者広告䞻たたは提携先が圓瀟りェブサむト・モバむルアプリ䞊に広告を掲茉するこずを蚱可する堎合があり、これら広告䞻から広告ぞの反応に基づく報酬を受けるこずがありたす。
© 著䜜暩: FINSIGHTS MEDIA PTE. LTD. 無断耇写・転茉を犁じたす。